Human Immunology, Pathophysiology, Immunotherapy (HIPI) France

Research

Date range: 1 December 2020 - 30 November 2021

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Human Immunology, Pathophysiology, Immunotherapy (HIPI) published between 1 December 2020 - 30 November 2021 which are tracked by the Nature Index.

Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Article Count and Share for Human Immunology, Pathophysiology, Immunotherapy (HIPI)
Count Share
11 1.77

Outputs by subject (Share)

Outputs by subject
Subject Count Share
11 1.77

Share output for the past 5 years

Share per year
2016 2017 2018 2019 2020
0.00 0.00 0.00 0.00 0.01

Compare Human Immunology, Pathophysiology, Immunotherapy (HIPI) with other institutions

Collaboration

Date range: 1 December 2020 - 30 November 2021

International vs. domestic collaboration by Share

  • 88.16% Domestic
  • 11.84% International

Hover over the graph to view the percentage of collaboration.


Top 10 domestic collaborators with Human Immunology, Pathophysiology, Immunotherapy (HIPI) by Share (65 total)

  1. Human Immunology, Pathophysiology, Immunotherapy (HIPI) and University of Paris (3.42)
    Human Immunology, Pathophysiology, Immunotherapy (HIPI)1.77
    University of Paris1.65
  2. Human Immunology, Pathophysiology, Immunotherapy (HIPI) and National Institute for Health and Medical Research (INSERM) (3.41)
    Human Immunology, Pathophysiology, Immunotherapy (HIPI)1.77
    National Institute for Health and Medical Research (INSERM)1.64
  3. Human Immunology, Pathophysiology, Immunotherapy (HIPI) and Assistance Publique-Hôpitaux de Paris (AP-HP) (2.98)
    Human Immunology, Pathophysiology, Immunotherapy (HIPI)1.58
    Assistance Publique-Hôpitaux de Paris (AP-HP)1.40
  4. Human Immunology, Pathophysiology, Immunotherapy (HIPI) and French National Centre for Scientific Research (CNRS) (2.26)
    Human Immunology, Pathophysiology, Immunotherapy (HIPI)1.48
    French National Centre for Scientific Research (CNRS)0.78
  5. Human Immunology, Pathophysiology, Immunotherapy (HIPI) and Sorbonne University (1.71)
    Human Immunology, Pathophysiology, Immunotherapy (HIPI)1.33
    Sorbonne University0.37
  6. Human Immunology, Pathophysiology, Immunotherapy (HIPI) and Curie Institute (1.54)
    Human Immunology, Pathophysiology, Immunotherapy (HIPI)0.79
    Curie Institute0.75
  7. Human Immunology, Pathophysiology, Immunotherapy (HIPI) and Imagine Institute (1.23)
    Human Immunology, Pathophysiology, Immunotherapy (HIPI)0.47
    Imagine Institute0.76
  8. Human Immunology, Pathophysiology, Immunotherapy (HIPI) and The French Alternative Energies and Atomic Energy Commission (CEA) (1.20)
    Human Immunology, Pathophysiology, Immunotherapy (HIPI)1.01
    The French Alternative Energies and Atomic Energy Commission (CEA)0.19
  9. Human Immunology, Pathophysiology, Immunotherapy (HIPI) and National Research Institute for Agriculture, Food and Environment (INRAE) (1.14)
    Human Immunology, Pathophysiology, Immunotherapy (HIPI)1.01
    National Research Institute for Agriculture, Food and Environment (INRAE)0.13
  10. Human Immunology, Pathophysiology, Immunotherapy (HIPI) and Biologie Cellulaire et Cancer (0.96)
    Human Immunology, Pathophysiology, Immunotherapy (HIPI)0.37
    Biologie Cellulaire et Cancer0.58

Top 10 international collaborators with Human Immunology, Pathophysiology, Immunotherapy (HIPI) by Share (44 total)

  1. Human Immunology, Pathophysiology, Immunotherapy (HIPI) and Harvard University (1.63)
    Human Immunology, Pathophysiology, Immunotherapy (HIPI)0.10
    Harvard University1.53
  2. Human Immunology, Pathophysiology, Immunotherapy (HIPI) and Université Libre de Bruxelles (ULB) (0.56)
    Human Immunology, Pathophysiology, Immunotherapy (HIPI)0.01
    Université Libre de Bruxelles (ULB)0.55
  3. Human Immunology, Pathophysiology, Immunotherapy (HIPI) and F. Hoffmann-La Roche AG (0.34)
    Human Immunology, Pathophysiology, Immunotherapy (HIPI)0.31
    F. Hoffmann-La Roche AG0.03
  4. Human Immunology, Pathophysiology, Immunotherapy (HIPI) and Ragon Institute of MGH, MIT and Harvard (0.26)
    Human Immunology, Pathophysiology, Immunotherapy (HIPI)0.08
    Ragon Institute of MGH, MIT and Harvard0.18
  5. Human Immunology, Pathophysiology, Immunotherapy (HIPI) and The Rockefeller University (0.26)
    Human Immunology, Pathophysiology, Immunotherapy (HIPI)0.14
    The Rockefeller University0.13
  6. Human Immunology, Pathophysiology, Immunotherapy (HIPI) and Massachusetts Institute of Technology (MIT) (0.21)
    Human Immunology, Pathophysiology, Immunotherapy (HIPI)0.08
    Massachusetts Institute of Technology (MIT)0.13
  7. Human Immunology, Pathophysiology, Immunotherapy (HIPI) and Broad Institute of MIT and Harvard (0.20)
    Human Immunology, Pathophysiology, Immunotherapy (HIPI)0.08
    Broad Institute of MIT and Harvard0.12
  8. Human Immunology, Pathophysiology, Immunotherapy (HIPI) and University of Pennsylvania (Penn) (0.17)
    Human Immunology, Pathophysiology, Immunotherapy (HIPI)0.10
    University of Pennsylvania (Penn)0.06
  9. Human Immunology, Pathophysiology, Immunotherapy (HIPI) and Bundesamt für Ausrüstung, Informationstechnik und Nutzung der Bundeswehr (BAAINBw) (0.16)
    Human Immunology, Pathophysiology, Immunotherapy (HIPI)0.10
    Bundesamt für Ausrüstung, Informationstechnik und Nutzung der Bundeswehr (BAAINBw)0.05
  10. Human Immunology, Pathophysiology, Immunotherapy (HIPI) and Charité - University Medicine Berlin (0.11)
    Human Immunology, Pathophysiology, Immunotherapy (HIPI)0.02
    Charité - University Medicine Berlin0.09

Relationships

Partner Institutions

Human Immunology, Pathophysiology, Immunotherapy (HIPI) is a research collaboration whose article contributions are accrued to its participating partner institutions below.